Posted Dec. 13, 2011 at 12:52 p.m.

Premium Lock Liquidia to pursue new pneumonia vaccine

Published: 2011-12-13 12:52:15
Updated: 2011-12-13 12:52:15

Liquidia Liquidia

The Research Triangle Park-based firm is working with PATH to conduct preclinical studies on a "next generation" pneumococcal vaccine that could be more effective than existing vaccines and more efficient to produce....

Read More
Read More

Copyright 2017 MedCity. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders